Article Details

Dechra Pharmaceuticals plc 27.0% potential upside indicated by RBC Capital Markets

Retrieved on: 2022-09-20 18:45:31

Tags for this article:

Click the tags to see associated articles and topics

Dechra Pharmaceuticals plc 27.0% potential upside indicated by RBC Capital Markets. View article details on hiswai:

Excerpt

RBC Capital Markets set a target price of 4,000 GBX for the company, which when compared to the Dechra Pharmaceuticals plc share price of 2,922 ...

Article found on: www.directorstalkinterviews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up